# A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

> clinical trial · VERIFIED · 2026-06-26

Status: RECRUITING · Sponsor: NiKang Therapeutics, Inc. · Condition: HR+ Breast Cancer

- Company: NiKang Therapeutics, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07029399

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.